196
Views
13
CrossRef citations to date
0
Altmetric
Original Research

One-Year Mortality in Patients with Cancer Cachexia: Association with Albumin and Total Protein

, ORCID Icon, , , , , , , , , , ORCID Icon & ORCID Icon show all
Pages 6775-6783 | Published online: 29 Aug 2021

References

  • FearonK, StrasserF, AnkerSD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–495. doi:10.1016/S1470-2045(10)70218-721296615
  • SchmidtSF, RohmM, HerzigS, Berriel DiazM. Cancer cachexia: more than skeletal muscle wasting. Trends Cancer. 2018;4(12):849–860. doi:10.1016/j.trecan.2018.10.00130470306
  • EvansWJ, MorleyJE, ArgilesJ, et al. Cachexia: a new definition. Clin Nutr. 2008;27:793–799. doi:10.1016/j.clnu.2008.06.01318718696
  • PenetMF, BhujwallaZM. Cancer cachexia, recent advances, and future directions. Cancer J. 2015;21(2):117–122. doi:10.1097/PPO.000000000000010025815852
  • CongM, SongC, XuH, et al.; Investigation on Nutrition Status and Clinical Outcome of Common Cancers (INSCOC) Group. The patient-generated subjective global assessment is a promising screening tool for cancer cachexia. BMJ Support Palliat Care. 2020. doi:10.1136/bmjspcare-2020-002296
  • Gatta A, Verardo A, Bolognesi M. Hypoalbuminemia [J]. Intern Emerg Med. 2012;7 Suppl 3:S193-9. doi:10.1007/s11739-012-0802-0.
  • MatsuzukaT, KiyotaN, MizusawaJ, et al.; Japan Clinical Oncology Group (JCOG) Head and Neck Cancer Study Group. Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a Phase II trial (JCOG0706-S2). Jpn J Clin Oncol. 2019;49(1):37–41. doi:10.1093/jjco/hyy14530364985
  • XuH, SongC, WangC, et al. Investigation on nutrition status and clinical outcome of patients with common cancers in Chinese patients: a multicenter prospective study protocol. Int J Clin Trials. 2020;7(2):94. doi:10.18203/2349-3259.ijct20201052
  • AminMB, GreeneFL, EdgeSB, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–99. doi:10.3322/caac.2138828094848
  • Santos DA, Dawson JA, Matias CN, et al. Reference values for body composition and anthropometric measurements in athletes [J]. PLoS One. 2014;9(5):e97846. doi:10.1371/journal.pone.0097846. eCollection 2014.
  • BuenoH, RossJS, WangY, et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993–2006. JAMA. 2010;303(21):2141–2147. doi:10.1001/jama.2010.74820516414
  • KellerU. Nutritional laboratory markers in malnutrition. J Clin Med. 2019;8(6):775. doi:10.3390/jcm8060775
  • NaumannP, EberleinJ, FarniaB, et al. Cachectic body composition and inflammatory markers portend a poor prognosis in patients with locally advanced pancreatic cancer treated with chemoradiation. Cancers (Basel). 2019;11(11):1655. doi:10.3390/cancers11111655
  • BlandKA, ZopfEM, HarrisonM, et al. Prognostic markers of overall survival in cancer patients attending a cachexia support service: an evaluation of clinically assessed physical function, malnutrition and inflammatory status. Nutr Cancer. 2020;1–11. doi:10.1080/01635581.2020.1800765.
  • SrdicD, PlestinaS, Sverko-PeternacA, NikolacN, SimundicAM, SamarzijaM. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value. Support Care Cancer. 2016;24(11):4495–4502. doi:10.1007/s00520-016-3287-y27236439
  • JouinotA, UlmannG, VazeilleC, et al. Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients. Clin Nutr. 2020;39(6):1893–1899. doi:10.1016/j.clnu.2019.08.00331443979
  • ViganoAAL, MoraisJA, CiuttoL, et al. Use of routinely available clinical, nutritional, and functional criteria to classify cachexia in advanced cancer patients. Clin Nutr. 2017;36(5):1378–1390. doi:10.1016/j.clnu.2016.09.00827793524
  • BrkicFF, KadletzL, JankB, MayerC, HeiduschkaG, BrunnerM. Impact of pretherapeutic neutrophil-to-lymphocyte ratio, serum albumin, body-mass index, and advanced lung cancer inflammation index on clinical outcome in sinonasal squamous cell carcinoma. J Craniomaxillofac Surg. 2020;48(1):33–37. doi:10.1016/j.jcms.2019.11.01031810849
  • ZhuangCL, ZhangFM, LiW, et al. Associations of low handgrip strength with cancer mortality: a multicentre observational study. J Cachexia Sarcopenia Muscle. 2020;11(6):1476–1486. doi:10.1002/jcsm.1261432910535